Gulf International Bank UK Ltd Cuts Stock Holdings in Bausch Health Companies Inc (NYSE:BHC)

Share on StockTwits

Gulf International Bank UK Ltd decreased its stake in shares of Bausch Health Companies Inc (NYSE:BHC) by 32.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,962 shares of the company’s stock after selling 1,933 shares during the period. Gulf International Bank UK Ltd’s holdings in Bausch Health Companies were worth $86,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in BHC. State of Wisconsin Investment Board boosted its position in shares of Bausch Health Companies by 80.1% during the first quarter. State of Wisconsin Investment Board now owns 399,620 shares of the company’s stock valued at $9,862,000 after buying an additional 177,764 shares during the last quarter. Clearbridge Investments LLC boosted its position in shares of Bausch Health Companies by 0.5% during the first quarter. Clearbridge Investments LLC now owns 2,897,282 shares of the company’s stock valued at $71,563,000 after buying an additional 14,610 shares during the last quarter. Advisory Services Network LLC boosted its position in shares of Bausch Health Companies by 12.2% during the first quarter. Advisory Services Network LLC now owns 18,600 shares of the company’s stock valued at $459,000 after buying an additional 2,025 shares during the last quarter. Nordea Investment Management AB boosted its position in Bausch Health Companies by 14.8% in the first quarter. Nordea Investment Management AB now owns 10,871 shares of the company’s stock worth $359,000 after purchasing an additional 1,400 shares during the last quarter. Finally, FMR LLC boosted its position in Bausch Health Companies by 14.4% in the first quarter. FMR LLC now owns 312,264 shares of the company’s stock worth $7,704,000 after purchasing an additional 39,276 shares during the last quarter. 56.01% of the stock is currently owned by institutional investors.

In other news, CEO Joseph C. Papa purchased 30,000 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were purchased at an average price of $23.31 per share, with a total value of $699,300.00. Also, EVP Christina Ackermann sold 3,418 shares of the company’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $22.45, for a total value of $76,734.10. The disclosure for this sale can be found here. 11.87% of the stock is owned by corporate insiders.

BHC stock opened at $20.62 on Friday. The stock’s fifty day simple moving average is $21.49 and its two-hundred day simple moving average is $23.10. The company has a current ratio of 1.21, a quick ratio of 0.92 and a debt-to-equity ratio of 8.94. Bausch Health Companies Inc has a 1-year low of $17.20 and a 1-year high of $27.72. The stock has a market cap of $6.76 billion, a P/E ratio of 4.51 and a beta of 0.85.

Bausch Health Companies (NYSE:BHC) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.03 EPS for the quarter, missing analysts’ consensus estimates of $1.06 by ($0.03). Bausch Health Companies had a negative net margin of 10.88% and a positive return on equity of 52.12%. The firm had revenue of $2.15 billion for the quarter, compared to analysts’ expectations of $2.15 billion. During the same period in the prior year, the company earned $0.93 EPS. The firm’s quarterly revenue was up 1.1% on a year-over-year basis. As a group, analysts forecast that Bausch Health Companies Inc will post 4.15 earnings per share for the current fiscal year.

Several research analysts have weighed in on BHC shares. Mizuho set a $45.00 price objective on Bausch Health Companies and gave the stock a “buy” rating in a research report on Thursday, June 20th. HC Wainwright boosted their price objective on Bausch Health Companies from $50.00 to $54.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. TD Securities raised Bausch Health Companies from a “hold” rating to a “buy” rating and set a $28.00 price objective on the stock in a research report on Thursday, August 15th. Barclays set a $28.00 price objective on Bausch Health Companies and gave the stock a “buy” rating in a research report on Monday, July 8th. Finally, Wells Fargo & Co reissued a “sell” rating on shares of Bausch Health Companies in a research report on Tuesday, September 17th. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and twelve have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $29.68.

Bausch Health Companies Profile

Bausch Health Companies Inc develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products.

Featured Article: Accumulation/Distribution

Want to see what other hedge funds are holding BHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bausch Health Companies Inc (NYSE:BHC).

Institutional Ownership by Quarter for Bausch Health Companies (NYSE:BHC)

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Ladenburg Thalmann Financial Services Inc. Buys 2,543 Shares of Seattle Genetics, Inc.
Ladenburg Thalmann Financial Services Inc. Buys 2,543 Shares of Seattle Genetics, Inc.
4,480 Shares in Sinclair Broadcast Group Inc  Acquired by Hexavest Inc.
4,480 Shares in Sinclair Broadcast Group Inc Acquired by Hexavest Inc.
Conagra Brands Inc  Stock Position Decreased by Landsberg Bennett & Dubbaneh LLC
Conagra Brands Inc Stock Position Decreased by Landsberg Bennett & Dubbaneh LLC
Ladenburg Thalmann Financial Services Inc. Sells 2,414 Shares of Pentair PLC
Ladenburg Thalmann Financial Services Inc. Sells 2,414 Shares of Pentair PLC
Gulf International Bank UK Ltd Sells 2,549 Shares of Canadian Natural Resources Ltd
Gulf International Bank UK Ltd Sells 2,549 Shares of Canadian Natural Resources Ltd
Gulf International Bank UK Ltd Cuts Stock Holdings in Bausch Health Companies Inc
Gulf International Bank UK Ltd Cuts Stock Holdings in Bausch Health Companies Inc


© 2006-2019 Ticker Report